Glucosamine sulfate - Environmental antibacterial activity

Clinical Rheumatology

Volumn 28, Issue 10, 2009, Pages 1221-1223

  Rozin, Alexander P ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Rambam Health Care Campus ^*  (Israel)

Author keywords

Arthryl; Environmental antibacterial activity; Glucosamine sulfate; Osteoarthritis

Indexed keywords

GLUCOSAMINE SULFATE; PHENYLBUTAZONE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM COLONY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; DRUG SCREENING; FUNGUS GROWTH; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CULTURE MEDIA; ESCHERICHIA COLI; GLUCOSAMINE; HUMANS; OSTEOARTHRITIS, KNEE;

EID: 69949130527     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1209-9     Document Type: Article

References (15)

1. Reginster JY, Deroisy R, Rovati LC (2001) Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomized, placebo-controlled clinical trial. Lancet 357:251-256
2. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR (2006) Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354:795-808
3. Altman RD, Abadie E, Avouac B et al (2005) Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. Osteoarthritis Cartilage 13:13-19
4. Rozin AP, Militianu D, Edoute Y (2004) OARSI response criteria in assessment of co-trimoxazole influence on refractory knee osteoarthritis during prophylaxis of recurrent UTI. EULAR-Berlin 2004. Ann Rheum Dis 63(Sup.1):358
5. Rozin A (2007) Is osteoarthritis an infection-associated disease and a target for chemotherapy? Chemotherapy 53:1-9
6. Rozin AP, Goldstein M, Sprecher H (2008) Antibacterial activity of glucosamine sulfate and chondroitine sulfate? Clin Exp Rheumatol 26:509-510
7. Lippiello L (2003) Glucosamine and chondroitin sulfate: Biological response modifiers of chondrocytes under simulated conditions of joint stress. Osteoarthritis Cartilage 11:335-342
8. Xing R, Liu S, Guo Z, Yu H, Li C, Ji X et al (2006) The antioxidant activity of glucosamine hydrochloride in vitro. Bioorg Med Chem 14:1706-1709
9. Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY, Oh HJ, Kim HY (2006) The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 54:2152-2163
10. Botha-Scheepers S, Watt I, Slagboom E, De Craen T, Meulenbelt I, Rosendaal FR, et al (2006) Innate production of tumor necrosis factor-alpha and interleukin-10 upon lypopolysaccharide stimulation are associated with radiological progression of knee osteoarthritis. ACR, p 266
11. Albillos A, De La Herra A, Gonzalez M, Moya JL, Calleja JL, Monserrat J et al (2003) Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37:208-217
12. Shaunak S, Thomas S, Gianasi E, Godwin A, Jones E, Teo I, Mireskandari K et al (2004) Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol 22:977-984
13. Loke WK, Lau SK, Yong LL, Khor E, Sum CK (2000) Wound dressing with sustained anti-microbial capability. J Biomed Mater Res 53:8-17
14. Morimoto M, Saimoto H, Usui H, Okamoto Y, Minami S, Shigemasa Y (2001) Biological activities of carbohydrate-branched chitosan derivates. Biomacromolecules 2:1133-1136
15. Andres Y, Giraud L, Gerente C, Le Cloirec P (2007) Antibacterial effects of chitosan powder: Mechanisms of action. Environ Technol 28:1357-1363